Sijimedtec Strengthens Latin America Strategy... Expands into 4 More Countries Including Puerto Rico

Market Expansion from 19 to 23 Countries

CJ MedTech, a specialist company in orthopedic implant research and manufacturing, is intensifying its efforts to expand into the Latin American market.

The representative product of Sigimedtec, the posterior spinal fixation device ANAX 5.5. Provided by Sigimedtec

On the 21st, CJ MedTech announced that it expanded its overseas presence from 19 countries, including Mexico, Brazil, China, and Ukraine, to 23 countries by newly entering Puerto Rico, the Dominican Republic, Nicaragua, and Peru last year.

With increased sales of its flagship products in these regions, overseas revenue in 2024 grew by 9% compared to the previous year. The company’s key growth products include the spinal posterior fixation device ANAX 5.5, the epidural lumbar interbody fusion cage Velofix TLIF, and the cervical standalone anterior fixation device Velofix SA, all showing continuous demand growth.

In particular, the ANAX 5.5 is a spinal posterior fixation device usable in various surgical environments, gaining trust in overseas markets due to its excellent fixation strength and design completeness. The ANAX OCT, used in cervical (neck) fusion surgery, also continues steady growth based on precise fixation strength and stability. The next-generation fixation device 'Innoverse' and the 3D-printed cervical cage 'UniSpace Stand-Alone C Cage,' both launched in Korea and the U.S. at the end of last year, are actively exploring the market and aiming for further expansion in Latin America.

Jung Jumi, CEO of CJ MedTech, stated, "Expanding collaboration with overseas medical professionals and developing products that reflect each country’s medical environment and surgical trends are key to enhancing global competitiveness. In particular, we plan to strengthen education and training for local medical staff to successfully establish ourselves in the four newly entered Latin American countries."

Previously, CJ MedTech signed an exclusive supply contract for 'NOVOSIS Trauma' with Johnson & Johnson MedTech. Through this, CJ MedTech exclusively supplies NOVOSIS Trauma to Johnson & Johnson MedTech, which then distributes and sells it first in Korea.

This content was produced with the assistance of AI translation services.